About Inactivated Hepatitis A Vaccine IP
The Inactivated Hepatitis A Vaccine IP embodies elite immunization with unrivaled quality and praiseworthy efficacy. Designed for instant savings through its cost-effective single-vial packaging, it offers rarefied protection for both adults and children above 12 months. This liquid, intramuscular vaccine is IP/BIS compliant, manufactured in India, and remains stable for a remarkable 36 months. Enhanced with Aluminum Hydroxide adjuvant and preserved with 2-phenoxyethanol, it ensures robust immunogenic response. Its clear-to-slightly opalescent appearance reflects its purity and premium formulation for dependable hepatitis A prevention.
Primary Competitive Advantages and Application Benefits
The Inactivated Hepatitis A Vaccine IP stands out for its rarefied cost-effectiveness and praiseworthy compliance with IP/BIS standards. Suitable for plant administration in healthcare settings, it excels in mass immunization campaigns and clinical environments. Its premium adjuvant and preservative composition enhance immunogenicity, making it ideal for both pediatric and adult use. Application media include public health programs, hospitals, and travel clinics, providing maximum preventive reach and trusted protection against Hepatitis A infection.
Sample Availability, Certifications, and Payment Terms
Premium samples of Inactivated Hepatitis A Vaccine IP are available upon request, ensuring thorough evaluation before procurement. All goods are shipped through secure goods transport networks, guaranteeing safe and timely domestic delivery. The vaccine holds all essential IP/BIS certifications, confirming its safety and efficacy. Flexible payment terms accommodate both traders and suppliers across India's domestic market, making procurement straightforward and cost-effective for healthcare providers and distributors.
FAQ's of Inactivated Hepatitis A Vaccine IP:
Q: How should the Inactivated Hepatitis A Vaccine IP be stored for optimal effectiveness?
A: The vaccine must be stored at 2C to 8C and should never be frozen. This ensures its stability and preserves its unrivaled immunogenic properties throughout its 36-month shelf life.
Q: What is the recommended dosage and route of administration for this vaccine?
A: The dosage is typically 0.5 ml for children and 1 ml for adults, delivered by intramuscular injection. Dosages should always be administered according to a physician's instructions.
Q: When is it suitable to administer the Inactivated Hepatitis A Vaccine IP?
A: This vaccine is appropriate for individuals aged 12 months and above, particularly when there is a risk of exposure to Hepatitis A, as part of routine immunization or before travel to endemic areas.
Q: Where can the Inactivated Hepatitis A Vaccine IP be used?
A: It is suitable for hospitals, clinics, immunization campaigns, and targeted health initiatives requiring Hepatitis A prevention. Its packaging allows for easy administration in diverse healthcare settings.
Q: What competitive advantages does the vaccine offer compared to other options?
A: The vaccine boasts elite, cost-effective single-vial packaging, IP/BIS certification, long shelf life, and compliance with domestic standards, making it a rarefied choice in the market.
Q: How does the adjuvant Aluminum Hydroxide contribute to the vaccine's effectiveness?
A: Aluminum Hydroxide acts as a premium adjuvant, enhancing the body's immune response to the inactivated Hepatitis A virus and boosting the rarity and efficacy of immunization outcomes.